- Home
- ZIM vs APLS Comparison
ZIM vs APLS Comparison
Compare ZIM & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZIM | APLS |
|---|---|---|
| Founded | 1945 | 2009 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.7B |
| IPO Year | 2021 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ZIM | APLS |
|---|---|---|
| Price | $20.20 | $22.34 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 5 | 20 |
| Target Price | $15.04 | ★ $32.16 |
| AVG Volume (30 Days) | 3.3M | ★ 4.0M |
| Earning Date | 03-11-2026 | 02-27-2026 |
| Dividend Yield | ★ 19.88% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 8.31 | 0.36 |
| Revenue | ★ $7,587,100,000.00 | $1,016,397,000.00 |
| Revenue This Year | N/A | $31.31 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $2.59 | $64.64 |
| Revenue Growth | 1.63 | ★ 42.11 |
| 52 Week Low | $11.04 | $16.10 |
| 52 Week High | $24.47 | $30.60 |
Technical Indicators
Market Signals| Indicator | ZIM | APLS |
|---|---|---|
| Relative Strength Index (RSI) | 40.69 | 46.85 |
| Support Level | $22.51 | $21.59 |
| Resistance Level | $22.61 | $23.93 |
| Average True Range (ATR) | 0.97 | 1.21 |
| MACD | -0.32 | 0.14 |
| Stochastic Oscillator | 3.64 | 63.64 |
Price Performance
Historical ComparisonAbout ZIM ZIM Integrated Shipping Services Ltd.
ZIM Integrated Shipping Services Ltd is an asset-light container liner shipping company. It offers tailored services, including land transportation and logistical services, specialized shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. Its services include Cargo Services, Digital Services, Schedules, and Shipping Trades and Lines. Geographically, it derives a majority of its revenue from the Pacific trade region.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.